US equities
|
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Bausch + Lomb
Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate
July 09, 2026
From
Bausch + Lomb
Via
Business Wire
Tickers
BLCO
TSX:BLCO
Bausch + Lomb Introduces Orphia™, an AI-Powered Digital Health Platform Built to Return Physicians to Patient Care
July 09, 2026
From
Bausch + Lomb
Via
Business Wire
Tickers
BLCO
TSX:BLCO
Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Optometry Annual Meeting
October 04, 2023
From
Bausch + Lomb
Via
Business Wire
Tickers
BLCO
TSX:BLCO
Bausch + Lomb and Heidelberg Engineering Announce the Introduction of SeeLuma™ Fully Digital Surgical Visualization Platform
April 13, 2023
From
Bausch + Lomb
Via
Business Wire
Tickers
BLCO
TSX:BLCO